Intellectual Property

  • August 27, 2026

    Peeps TM Suit Hops Along But Rival's Candy Can't Be Blocked

    A New Jersey federal judge has rejected a bid to toss Peeps maker's trademark infringement suit against a rival candy maker, but he also refused to block the rival from selling bunny-shaped marshmallows, finding that it's unlikely consumers would be confused by the candies' different packaging.

  • August 27, 2026

    Ugg-Maker Beats Rival Footwear Co.'s Antitrust Suit, For Now

    A California federal judge on Thursday tossed Quince's antitrust suit alleging Deckers uses sham trade dress litigation to block rivals, ruling Quince didn't sufficiently plead a sham litigation exception to the Noerr-Pennington doctrine, which immunizes businesses from antitrust liability for petitioning activity, but allowed Quince a chance to amend.

  • August 27, 2026

    Boeing Calls Moon Tech Discovery Demand A 'Goose Chase'

    The Boeing Co. has pushed back against Colorado-based Wilson Aerospace's bid to force the disclosure of nearly 12 years' worth of financial records in an intellectual property dispute over technology used in a NASA moon exploration program, calling the discovery request "overbroad and unduly burdensome."

  • August 27, 2026

    Quectel Owes $3M For Infringing Philips Patent, Jury Says

    A Delaware federal jury awarded $3 million in damages Thursday and found Quectel Wireless Solutions had willfully infringed a telecommunications patent held by Dutch consumer electronics giant Philips.

  • August 27, 2026

    5th Circ. Backs FDA, Pharma Cos. In GLP-1 Shortage Fight

    The U.S. Food and Drug Administration did not unlawfully remove blockbuster GLP-1 medications made by Eli Lilly & Co. and Novo Nordisk from the national drug shortage list, the Fifth Circuit ruled Thursday, handing a loss to compounding pharmacies that produce copycat doses of the drugs.

  • August 27, 2026

    Guardant Suits Against Tempus AI Clear Dismissal Bids

    A Delaware federal judge has refused to throw out litigation accusing Tempus AI Inc. of infringing Guardant Health Inc. patents covering technology used to analyze cancer-related genetic data and help guide testing and treatment.

  • August 27, 2026

    Feds Want Ex-Google Engineer To Get Over 5 Yrs For AI Theft

    Prosecutors have urged a California federal judge to sentence ex-Google software engineer Linwei Ding to nearly 6 years in prison for stealing artificial intelligence trade secrets, while Ding argued that the government's suggestion is based on speculative evidence and he deserves only home confinement since he was acquitted of economic espionage.

  • August 27, 2026

    Sod Co. Seeks Sanctions Over Missing Trade Secrets Files

    A Colorado sod company asked a federal judge for sanctions in its trade secrets suit against former workers and competing businesses, arguing they failed to preserve electronic files that could show whether they possessed, transferred or used the company's confidential information.

  • August 27, 2026

    USPTO Sets Radiation Monitoring Patent Order As Informative

    The U.S. Patent and Trademark Office has added weight to a Patent Trial and Appeal Board order from earlier this year that undid a decision rejecting an RNA patent application.

  • August 27, 2026

    Albright Cuts $9M IP Verdict Against GlobalFoundries To $1M

    A Texas federal judge has reduced a $9.2 million jury verdict against semiconductor-maker GlobalFoundries Inc. for patent infringement to $1 million, faulting several aspects of Katana Silicon Technologies LLC's damages theory.

  • August 27, 2026

    Meta Staves Off 3D Artist's AI Training Suit, For Now

    A California federal judge has dismissed a Los Angeles-based 3D artist's proposed class action alleging Meta Platforms Inc. removed copyright management information from art that was used to train artificial intelligence, but gave the artist a chance to cure the suit's issues.

  • August 27, 2026

    McKool Smith Adds Veteran Trial Atty In Dallas

    McKool Smith has bulked up its litigation offerings in Dallas with the addition of a seasoned trial attorney from a solo practice who also brings decades of BigLaw experience.

  • August 27, 2026

    Womble Bond Asks To Drop Dutch Software Client Over Rift

    Womble Bond Dickinson is looking to pull its representation of a Dutch software company after five years of a bitter trademark battle, citing a "fundamental disagreement" that has allegedly made it impossible for the firm to move forward as counsel of record.

  • August 27, 2026

    Fed. Circ. Hands Losses To Apple On 3 Smart Mobile Patents

    Smart Mobile Technologies LLC came out victorious in a set of Federal Circuit decisions Thursday in a patent fight involving Apple Inc., with the appeals court refusing to revive the tech giant's challenges to certain patent claims and reversing the Patent Trial and Appeal Board's invalidation of other claims.

  • August 27, 2026

    Ex-Cannabis Tech Execs Say CEO Defamed Them After Firing

    Two former executives at Alpine IQ Inc. are suing the company and its CEO in Colorado federal court, alleging they were defamed when he falsely accused them of stealing Alpine's intellectual property after he summarily fired them.

  • August 26, 2026

    Chemical Co. Reps Can't Dissolve $1.9M Trade Secret Verdict

    A federal judge on Tuesday rejected a request by three chemical sales representatives to undo a $1.9 million jury verdict for their former employer in a trade secret dispute, ruling that Silver Fern Chemical Inc. clearly demonstrated that they took confidential customer information that was valuable and not readily accessible elsewhere.

  • August 26, 2026

    9th Circ. Panel Won't Revisit Boeing's $72M Trade Secret Loss

    A Ninth Circuit panel has rejected Boeing's bid for a panel rehearing of its August 2025 decision reinstating a $72 million jury verdict for electric jet startup Zunum Aero Inc. in a trade secret dispute, spurning the aerospace giant's fresh argument that the case belongs in the Federal Circuit because of the patent counterclaims involved.

  • August 26, 2026

    Eton's Galzin TM And False Ad Suit Survives Dismissal Bid

    Eton Pharmaceuticals can proceed with trademark infringement and false advertising claims accusing Extreme V of marketing a dietary supplement as a Wilson disease treatment, with a Michigan federal judge finding that Extreme V's defenses and factual challenges could not dispose of the case at the pleading stage.

  • August 26, 2026

    Fla. Judge Trims Claims In Bitcoin ATM Code Theft Suit

    A Florida federal judge allowed most of an Illinois software company's claims of bitcoin ATM source code theft to proceed against its former developer and others, but tossed two counts of conversion after finding the allegations couldn't be sustained. 

  • August 26, 2026

    Squires Institutes 6 Patent Reviews, Rejects 5 Others

    U.S. Patent and Trademark Office Director John Squires has instituted six patent reviews and denied five other requests in his latest round of decisions.

  • August 26, 2026

    Fed. Circ. Brings Back Telecom Patent Challenged By Cisco

    The Federal Circuit on Wednesday restored a patent that the Patent Trial and Appeal Board found invalid after Cisco Systems Inc. challenged it, disagreeing with the claim construction the board adopted.

  • August 26, 2026

    Joe Gibbs Racing Beats Ex-Director's Cyber Trespass Claims

    Joe Gibbs Racing's former competition director can't pursue counterclaims alleging the NASCAR super team violated state and federal cyber hacking statutes when it allegedly accessed "off-limits" information on his devices during a forensic review, a North Carolina federal judge ruled Wednesday in their high-profile trade secrets dispute.

  • August 26, 2026

    Ex-Josh Cellars Exec Balks At Bid For Lit Funding Probe  

    Companies behind the Josh Cellars wine brand should be banned from probing a former executive's litigation funding deal during a November trademark royalties trial, the executive told a Connecticut state court Tuesday, arguing his cash sources are irrelevant to his attempt to seek more than $4 million through contract and fiduciary duty claims.

  • August 26, 2026

    Boeing Beats Bid For More Depos In Moon Mission IP Suit

    A Colorado aerospace company cannot conduct additional depositions in its lawsuit accusing The Boeing Co. of stealing patented technology for a NASA moon exploration program, a Washington federal magistrate judge ruled.

  • August 26, 2026

    Canva Loses Sanctions Bid Targeting Prolific Patent Lawyer

    Website builder Canva US Inc. has been denied a bid to sanction one of the most prolific patent attorneys over the last few years who sued on behalf of HyperQuery LLC as a Texas federal judge ruled that HyperQuery's theory was not "exceptionally meritless."

Expert Analysis

  • Have Iconic Twitter Trademarks Been Abandoned?

    Author Photo

    A set of lawsuits concerning the status of X Corp.'s "Twitter" and "tweet" trademarks, which will potentially be considered abandoned in July, will provide instructive insights into how trademark owners can defend against abandonment claims, say attorneys at Bradley Arant.

  • Google's Scraping Suit Asks How Far DMCA Protections Go

    Author Photo

    A California federal court's decision in Google v. SerpApi will spotlight a long-developing judicial split over how to apply the Digital Millennium Copyright Act’s ban on circumventing a copyright holder’s access controls, an increasingly important point in litigation over web scraping and artificial intelligence training, say attorneys at Jenner & Block.

  • Trial Advocacy Lessons From 3 Oscar-Nominated Films

    Author Photo

    Several films up for best picture at this weekend’s Academy Awards provide useful tips for trial lawyers, from the power of a dramatic opening to the importance of pivoting when the unexpected happens, say attorneys at Robins Kaplan.

  • Series

    Podcasting Makes Me A Better Lawyer

    Author Photo

    Podcasting has changed how I ask questions and connect with people, sharpening my ability to listen without interrupting or prejudging, and bringing me closer to what law is meant to be: a human profession grounded in understanding, judgment and trust, says Donna DiMaggio Berger at Becker.

  • Patent Eligibility Bulletin: Steps To Consider As USPTO Shifts

    Author Photo

    Recent memoranda from the U.S. Patent and Trademark Office, along with some of the first patents issued under Director John Squires, indicate a recalibration of the subject matter eligibility landscape, signaling a renewed emphasis on concrete technological improvements and a potentially pro-AI stance, say attorneys at Banner Witcoff.

  • Opinion

    Fed. Circ. Must Bury Design Patent Doctrinal Zombies

    Author Photo

    After recently finding noninfringement in Range of Motion Products v. Armaid, the Federal Circuit must rehear the case to confront two troublesome doctrines of design patent law claim construction — feature filtration and claim verbalization — that have lingered for decades and intensified in recent years, say attorneys at McAndrews Held.

  • Why La. Ruling May Open NIL Deals For Int'l Student-Athletes

    Author Photo

    A Louisiana federal court's decision to deny a motion to dismiss in Poa v. Jaddou, a case over whether international student-athletes may engage in name, image and likeness deals, signals that courts are willing to challenge rigid interpretations of immigration law in light of modern collegiate athletics, say attorneys at Shook Hardy.

  • Weighing Confusion Claims In Shoes-NFL Steakhouse TM Suit

    Author Photo

    A recent New York federal infringement complaint by 1587 Sneakers against Patrick Mahomes and Travis Kelce's Kansas City steakhouse 1587 Prime confronts the thorny question of how much operating in different industries should factor into likelihood-of-confusion analysis and why consumer perception can matter most in trademark fights, says Nate Garhart at Spencer West.

  • Unique Issues Facing Brand-Compounder Patent Litigation

    Author Photo

    Recent litigation and potential enforcement action against Hims & Hers Health raise questions about how compounders and branded pharmaceuticals companies would be positioned in patent litigation as compared to generics companies, which would require strategies different from those that would be used in traditional Hatch-Waxman Act litigation, say attorneys at Morgan Lewis.

  • Series

    Volunteering With Scouts Makes Me A Better Lawyer

    Author Photo

    Serving as an assistant scoutmaster for my son’s troop reaffirmed several skills and principles crucial to lawyering — from the importance of disconnecting to the value of morality, says Michael Warren at McManis Faulkner.

  • AI Communications May Be Discoverable In Patent Litigation

    Author Photo

    A New York federal court's recent determination that a defendant's correspondence with an artificial intelligence tool was not protected by attorney-client privilege may have significant ramifications for patent matters, highlighting the risk of AI use in patent prosecution and litigation tasks, say attorneys at Seed IP.

  • Series

    Law School's Missed Lessons: In Court, It's About Storytelling

    Author Photo

    Law school provides doctrine, cases and hypotheticals, but when lawyers step into the courtroom, they must learn the importance of clarity, credibility, memorability and preparation — in other words, how to tell simple, effective stories, say Nicholas Steverson and Danielle Trujillo at Wheeler Trigg, and Lisa DeCaro at Courtroom Performance.

  • High Court's 'Skinny Label' Case May Tackle Wider Questions

    Author Photo

    The U.S. Supreme Court's upcoming decision in Hikma v. Amarin will have important ramifications for broader debates over what defines a generic version of a drug, and the pending case is already altering patent practice, say attorneys at Taft.

  • Aligning Microsoft Tools With NYC Bar AI Recording Guidance

    Author Photo

    The New York City Bar Association’s recently issued formal opinion, providing ethical guidance on artificial intelligence-assisted recording, transcription and summarization, raises immediate questions about data governance and e-discovery for companies that use Microsoft 365 and Copilot, say Staci Kaliner, Martin Tully and John Collins at Redgrave.

  • FDA's Biosimilarity Guidance Holds Uncertain Implications

    Author Photo

    The U.S. Food and Drug Administration's new draft guidance aimed at simplifying the biosimilarity demonstration process may not be enough to overcome the barriers that have historically constrained biosimilar competition, and could affect biosimilar access in unexpected ways, say analysts at Analysis Group.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.